Svenska Cellulosa Aktiebolaget (SCA) (SCA-B.ST)

Svenska Cellulosa Aktiebolaget (SCA) (SCA-B.ST) Trading on MT5 at XM

At XM we offer Svenska Cellulosa Aktiebolaget (SCA) (SCA-B.ST) stocks as cash CFDs. Our cash CFDs stocks are undated transactions that aim to replicate the cash price of the underlying stock, and so they are adjusted for any relevant corporate actions.

Open a Demo Account
Open an Account

Risk warning: FX and CFD trading involves a high risk of loss.

About Svenska Cellulosa Aktiebolaget (SCA) (SCA-B.ST) Trading

SCA (Svenska Cellulosa Aktiebolaget) is a Swedish company that manufactures pulp and paper, with its main products including wood pulp, publication paper, forest-based biofuel and solid-wood products. The company was founded in 1929, and its present headquarters is in Stockholm, Sweden. The SCA stock, SCA-B.ST, is traded on Nasdaq Stockholm stock exchange.

Trading Conditions

Margin requirement 10 %
Spreads as low as 0.19
Symbols SCA
Description SCA
Min. Price Fluctuation 0.01000
Value of Minimum Price Fluctuation SEK 0.1
Value of 1 lot 10 Shares
Min/Max Trade Size 1/602
Swap Value in Margin Currency Long -2.49 %
Swap Value in Margin Currency Short -3.51 %
Limit and Stop Levels** 0.05
Total Volume Limit (per client)*** 6267
Trading time (server time) 10:10-18:15 (GMT +3)
** Min. level for placing pending orders at a current market price.

*** Note that the maximum trading volume for SCA per client is 6267 lots. This limit will be reviewed on a daily basis and updated according to the value of the instrument.

How to Start Trading Svenska Cellulosa Aktiebolaget (SCA) (SCA-B.ST)?

Step 1

Open an XM Real Account


Step 2

Download and login to the MT5 platform


Step 3

Double-click on Svenska Cellulosa Aktiebolaget (SCA) (SCA-B.ST) from the “Market Watch” to open an order for this instrument.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.